NDC 0703-4685

mitoXANTRONE

Mitoxantrone

mitoXANTRONE is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is Mitoxantrone Hydrochloride.

Product ID0703-4685_031f9934-217e-40c4-b623-92a44b5831ac
NDC0703-4685
Product TypeHuman Prescription Drug
Proprietary NamemitoXANTRONE
Generic NameMitoxantrone
Dosage FormInjection, Solution, Concentrate
Route of AdministrationINTRAVENOUS
Marketing Start Date2006-04-11
Marketing CategoryANDA / ANDA
Application NumberANDA077356
Labeler NameTeva Parenteral Medicines, Inc.
Substance NameMITOXANTRONE HYDROCHLORIDE
Active Ingredient Strength2 mg/mL
Pharm ClassesTopoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0703-4685-01

1 VIAL, MULTI-DOSE in 1 CARTON (0703-4685-01) > 10 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date2006-04-11
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0703-4685-01 [00703468501]

mitoXANTRONE INJECTION, SOLUTION, CONCENTRATE
Marketing CategoryANDA
Application NumberANDA077356
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2006-04-11

Drug Details

Active Ingredients

IngredientStrength
MITOXANTRONE HYDROCHLORIDE2 mg/mL

OpenFDA Data

SPL SET ID:4d0f0f1a-31af-40fa-9c64-e90891fa6ce4
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197989
  • UPC Code
  • 0307034680018
  • 0307034685013
  • Pharmacological Class

    • Topoisomerase Inhibitor [EPC]
    • Topoisomerase Inhibitors [MoA]

    NDC Crossover Matching brand name "mitoXANTRONE" or generic name "Mitoxantrone"

    NDCBrand NameGeneric Name
    0703-4680mitoXANTRONEmitoXANTRONE
    0703-4685mitoXANTRONEmitoXANTRONE
    0703-4686mitoXANTRONEmitoXANTRONE
    61703-343MitoxantroneMitoxantrone
    63323-132MitoxantroneMITOXANTRONE HYDROCHLORIDE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.